Page last updated: 2024-09-03

gyki 53655 and Atrophy

gyki 53655 has been researched along with Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barks, JD; Liu, XH; Wang, P	1

Other Studies

1 other study(ies) available for gyki 53655 and Atrophy

Article	Year
The non-competitive AMPA antagonist LY 300168 (GYKI 53655) attenuates AMPA-induced hippocampal injury in neonatal rodents. Neuroscience letters, 1997, Oct-10, Volume: 235, Issue:1-2 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Animals, Newborn; Atrophy; Benzodiazepines; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hippocampus; Injections, Intraperitoneal; N-Methylaspartate; Pyramidal Cells; Rats; Rats, Sprague-Dawley	1997

Article

Year

The non-competitive AMPA antagonist LY 300168 (GYKI 53655) attenuates AMPA-induced hippocampal injury in neonatal rodents.

Neuroscience letters, 1997, Oct-10, Volume: 235, Issue:1-2

Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Animals, Newborn; Atrophy; Benzodiazepines; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hippocampus; Injections, Intraperitoneal; N-Methylaspartate; Pyramidal Cells; Rats; Rats, Sprague-Dawley

1997